Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group

Introduction The risk of HBV reactivation is important in lymphoma patients receiving immunosuppressive chemotherapy containing steroids or anti-CD20 antibodies. We aimed to establish the prevalence of HBV Ag and anti-HBc serologic positive results in patients with non-Hodgkin lymphoma (NHL) and chr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ewa Kalinka, Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Joanna Barankiewicz, Elżbieta Zalewska, Igor Symonowicz, Ewa Lech-Marańda
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2019
Materias:
R
Acceso en línea:https://doaj.org/article/ce78f69cb9b744468c38171ba90af4e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!